Biological medicines – generic substitution, pharmaceutical markets, and prescription guidelines

This register research project studies the effects of the generic substitution of biological medicines on the use, costs, and reimbursement costs of health insurance. It also examines the life cycle, competition and market situation, and availability of biological medicines after the introduction of the generic substitution of biological medicines. In addition, the guidance for and supervision of the prescription of biological medicines will be studied.

The project is part of a consortium study whose main responsible parties are Kela, the Department of Pharmacy at the University of Eastern Finland and the Department of Pharmacy at the University of Helsinki.

Researchers

• Kati Sarnola, Principal Investigator
• Hanna Koskinen
• Klaudia Kaustiala
• Pekka Heino
• Heini Kari
• Hanna Rättö
• Terhi Kurko
• Markus Kainu
• Monika Fuss
• Iiro Ahomäki

Duration of the project

1.1.2024–31.12.2028

Privacy policy (in Finnish)

Partners

• Department of Pharmacy, University of Eastern Finland (uef.fi)
• Department of Pharmacy, University of Helsinki (helsinki.fi)